Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Shares Issued (2018 - 2025)

Dna X (SONM) has disclosed Shares Issued for 7 consecutive years, with $4.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 34507.14% year-over-year to $4.8 million, compared with a TTM value of $10.0 million through Sep 2025, up 164.53%, and an annual FY2024 reading of $48000.0, down 88.54% over the prior year.
  • Shares Issued was $4.8 million for Q3 2025 at Dna X, down from $5.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $14.4 million in Q3 2022 and bottomed at -$9.0 million in Q4 2021.
  • Average Shares Issued over 4 years is $2.2 million, with a median of $53000.0 recorded in 2024.
  • The sharpest move saw Shares Issued crashed 97.62% in 2021, then skyrocketed 34507.14% in 2025.
  • Year by year, Shares Issued stood at -$9.0 million in 2021, then surged by 100.01% to $1000.0 in 2022, then crashed by 375100.0% to -$3.8 million in 2024, then soared by 229.2% to $4.8 million in 2025.
  • Business Quant data shows Shares Issued for SONM at $4.8 million in Q3 2025, $5.4 million in Q2 2025, and $3.5 million in Q1 2025.